Literature DB >> 24953479

Gender differences in a cohort of major depressive patients: further evidence for the male depression syndrome hypothesis.

Jean-Michel Azorin1, Raoul Belzeaux2, Eric Fakra2, Arthur Kaladjian2, Elie Hantouche3, Sylvie Lancrenon4, Marc Adida2.   

Abstract

BACKGROUND: Previous studies have shown that major depressive patients may differ in several features according to gender, but the existence of a specific male depressive syndrome remains controversial.
METHODS: As part of the EPIDEP National Multisite French Study of 493 consecutive DSM-IV major depressive patients evaluated in at least two semi-structured interviews 1 month apart, 125 (27.7%) were of male gender, whereas 317 (72.3%) were female, after exclusion of bipolar I patients.
RESULTS: Compared to women, men were more often married, had more associated mixed features, with more bipolar disorder NOS, more hyperthymic temperaments, and less depressive temperaments. Women had an earlier age at onset of depression, more depressive episodes and suicide attempts. A higher family loading was shown in men for bipolar disorder, alcohol use disorder, impulse control disorders and suicide, whereas their family loading for major depressive disorder was lower. Men displayed more comorbidities with alcohol use, impulse control, and cardiovascular disorders, with lower comorbidities with eating, anxiety and endocrine/metabolic disorders. The following independent variables were associated with male gender: hyperthymic temperament (+), alcohol use disorder (+), impulse control disorders (+), and depressive temperament (-). LIMITATIONS: The retrospective design and the lack of specific tools to assess the male depressive syndrome.
CONCLUSION: Study findings may lend support to the male depression syndrome concept and draw attention to the role of hyperthymic temperament, soft bipolarity as well as comorbidities as determinants of this syndrome. The latter could help recognize an entity which is probably underdiagnosed, but conveys a high risk of suicide and cardiovascular morbidity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gender; Major depression; Male depressive syndrome; Men; Sex; Women

Mesh:

Year:  2014        PMID: 24953479     DOI: 10.1016/j.jad.2014.05.058

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Ecological momentary assessment of HIV versus reproductive health symptoms in women of differing reproductive stages living with HIV.

Authors:  Rebecca Schnall; Jianfang Liu; Nancy Reame
Journal:  Menopause       Date:  2019-12       Impact factor: 2.953

2.  Prevalence, symptomatology, risk factors and healthcare services utilization regarding paternal depression in Germany: study protocol of a controlled cross-sectional epidemiological study.

Authors:  Julia Albicker; Lars P Hölzel; Jürgen Bengel; Katharina Domschke; Levente Kriston; Miriam A Schiele; Fabian Frank
Journal:  BMC Psychiatry       Date:  2019-09-18       Impact factor: 3.630

3.  Residential Road Traffic Noise and High Depressive Symptoms after Five Years of Follow-up: Results from the Heinz Nixdorf Recall Study.

Authors:  Ester Orban; Kelsey McDonald; Robynne Sutcliffe; Barbara Hoffmann; Kateryna B Fuks; Nico Dragano; Anja Viehmann; Raimund Erbel; Karl-Heinz Jöckel; Noreen Pundt; Susanne Moebus
Journal:  Environ Health Perspect       Date:  2015-11-25       Impact factor: 9.031

4.  How Does Sex Influence Multimorbidity? Secondary Analysis of a Large Nationally Representative Dataset.

Authors:  Karolina Agur; Gary McLean; Kate Hunt; Bruce Guthrie; Stewart W Mercer
Journal:  Int J Environ Res Public Health       Date:  2016-03-31       Impact factor: 3.390

5.  Gender Differences in the Clinical Characteristics of Psychotic Depression: Results from the CRESCEND Study.

Authors:  Seon-Cheol Park; Søren Dinesen Østergaard; Jae-Min Kim; Tae-Youn Jun; Min-Soo Lee; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.